Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other Non-Current Assets (2021 - 2025)

Prime Medicine filings provide 5 years of Other Non-Current Assets readings, the most recent being $13.7 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $13.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.7 million, a N/A change, with the full-year FY2025 number at $13.7 million, changed N/A from a year prior.
  • Other Non-Current Assets hit $13.7 million in Q4 2025 for Prime Medicine, roughly flat from $13.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $14.1 million in Q3 2024 to a low of $779000.0 in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $13.5 million (2022), compared with a mean of $12.0 million.
  • Biggest five-year swings in Other Non-Current Assets: crashed 87.46% in 2022 and later rose 4.19% in 2024.
  • Prime Medicine's Other Non-Current Assets stood at $13.1 million in 2021, then crashed by 87.46% to $1.6 million in 2022, then plummeted by 52.67% to $779000.0 in 2023, then surged by 1705.13% to $14.1 million in 2024, then decreased by 2.64% to $13.7 million in 2025.
  • The last three reported values for Other Non-Current Assets were $13.7 million (Q4 2025), $13.7 million (Q3 2025), and $13.7 million (Q2 2025) per Business Quant data.